2024 annual financial data

Edesa Biotech 2024 Operating margin

Direct answer

Operating margin was Not calculable.

Operating income was -7.01M USD and net income was -6.17M USD.
Operating cash flow was -4.89M USD.

Get free Edesa Biotech email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-7.01M USD
Net income
-6.17M USD
Operating cash flow
-4.89M USD